A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)

Clinical trial NCT05225324 · COMPLETED

Trial details

NCT number: NCT05225324
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Parkinson Disease

Start date: 2021-06-03
Primary completion: 2025-03-20
Enrollment: 702

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.